CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 56 filers reported holding CARA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $79 | -54.3% | 16,124 | 0.0% | 0.03% | -57.1% |
Q4 2022 | $173 | -99.9% | 16,124 | 0.0% | 0.06% | +14.5% |
Q3 2022 | $151,000 | +2.7% | 16,124 | 0.0% | 0.06% | -3.5% |
Q2 2022 | $147,000 | -25.0% | 16,124 | 0.0% | 0.06% | +29.5% |
Q1 2022 | $196,000 | 0.0% | 16,124 | 0.0% | 0.04% | +76.0% |
Q4 2021 | $196,000 | -21.3% | 16,124 | 0.0% | 0.02% | -40.5% |
Q3 2021 | $249,000 | +8.3% | 16,124 | 0.0% | 0.04% | -41.7% |
Q2 2021 | $230,000 | -61.7% | 16,124 | -73.0% | 0.07% | -73.7% |
Q1 2015 | $600,000 | -24.5% | 59,713 | -25.1% | 0.27% | -9.3% |
Q4 2014 | $795,000 | +5.6% | 79,713 | -11.1% | 0.30% | +23.3% |
Q3 2014 | $753,000 | – | 89,713 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
XTX Topco Ltd | 52,025 | $147,231 | 0.03% |